12.03

1.39% -0.17

After Hours: 12.03

Pulse Biosciences Inc (PLSE)

Overview News Price History Option Chain Financials Discussions Forecast

Pulse Biosciences Inc stock is currently priced at $12.03, with a 24-hour trading volume of 74,073. It has seen a -1.39% decreased in the last 24 hours and a +56.44% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $12.55 pivot point. If it approaches the $11.59 support level, significant changes may occur.

Previous Close:

$12.20

Open:

$11.97

24h Volume:

74,073

Market Cap:

$664.36M

Revenue:

Net Income/Loss:

$-42.21M

P/E Ratio:

-9.8607

EPS:

-1.22

Net Cash Flow:

$-33.16M

1W Performance:

-2.83%

1M Performance:

+56.44%

6M Performance:

+27.30%

1Y Performance:

+82.83%

1D Range:

$11.60

$12.40

52W Range:

$3.78

$14.96

Pulse Biosciences Inc Stock (PLSE) Company Profile

Name

Pulse Biosciences Inc

Sector

Healthcare (1204)

Industry

Medical Instruments & Supplies (59)

Phone

650-697-3939

Address

3957 Point Eden Way, Hayward, CA

Employee

Twitter

@PulseBioNPS

Next Earnings Date

2024-06-06

Latest SEC Filings

PLSE's Discussions on Twitter

Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-27-21	Initiated	Stephens	Overweight
Mar-11-21	Initiated	Maxim Group	Buy
Jan-26-21	Reiterated	H.C. Wainwright	Buy
May-12-20	Upgrade	H.C. Wainwright	Neutral → Buy
Feb-14-20	Downgrade	H.C. Wainwright	Buy → Neutral
Feb-25-19	Initiated	H.C. Wainwright	Buy

View All

Pulse Biosciences Inc Stock (PLSE) Latest News

Pulse Biosciences (NASDAQ:PLSE) Shares Down 4.6% - MarketBeat

MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Stock Price Up 4.3% - MarketBeat

MarketBeat

8 Short Squeeze Stocks That Could Take Off | Investing | U.S. News - U.S News & World Report Money

U.S News & World Report Money

Cibc World Markets Corp Cuts Stock Position in Align Technology, Inc. (NASDAQ:ALGN) - Defense World

Defense World

Cibc World Markets Corp Buys New Holdings in NNN REIT, Inc. (NYSE:NNN) - Defense World

Defense World

Maximus, Inc. (NYSE:MMS) Position Raised by TD Asset Management Inc - Defense World

Defense World

Pulse Biosciences Inc Stock (PLSE) Financials Data

Pulse Biosciences Inc (PLSE) Net Income 2024

PLSE net income (TTM) was -$42.21 million for the quarter ending December 31, 2023, a +27.85% increase year-over-year.

Pulse Biosciences Inc (PLSE) Cash Flow 2024

PLSE recorded a free cash flow (TTM) of -$33.16 million for the quarter ending December 31, 2023, a +30.06% increase year-over-year.

Pulse Biosciences Inc (PLSE) Earnings per Share 2024

PLSE earnings per share (TTM) was -$0.89 for the quarter ending December 31, 2023, a +49.43% growth year-over-year.

Pulse Biosciences, Inc., a clinical-stage medical technology company, develops therapeutic tissue treatment platform based on its proprietary nano-pulse stimulation (NPS) technology. Its NPS is a non-thermal, precise, and focal drug-free tissue treatment technology that initiates cell death within treated tissue used in oncology, dermatology/aesthetics, minimally invasive, and veterinary applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.